BioPharma Dive – AI / Data
Roche stops work on experimental SMA drug
Helixgate AI & Biotech Collaboration Series + Helixgate Industry Nights brings together leaders and professionals from biotechnology, pharma, artificial intelligence, science, technology, medicine and healthcare for an evening of industry insights, networking and collaboration.
Date: October 22, 2026
Location: Del Mar Social, San Diego, California
Reserve your spot and purchase tickets on Eventbrite:
https://www.eventbrite.com/e/helixgate-ai-biotech-collaboration-series-helixgate-industry-nights-tickets-1998469781915?aff=oddtdtcreator
The treatment, tozorakimab, succeeded where other similar therapies failed and could help a broader group of COPD patients than Dupixent.
Worth up to $2 billion, the deal is centered around a drug that could lead to faster and more complete control of allergic conditions than Novartis and Roche’s popular medicine.
FDA warning letter accuses Bausch & Lomb of lacking commitment to remediation
Deep dive: Psychedelics back on FDA’s doorstep
‘Patients are not a renewable resource’: Rethinking rare disease R&D
Where female participation in clinical trials has caught up — and where gaps remain
Novartis halts TREM2 targeting ALS program in 4th trial stumble in a month
Sling catches $123M series C for thyroid eye disease pill
-
Fierce Biotech6 months ago
Scientists turn pig semen extract into eye drops that kill cancer in mice
-
Endpoints News6 months ago
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
-
Uncategorized6 months agoNovartis buys Synnovation’s PI3Kα inhibitors for $3 billion
-
Nature Biotechnology6 months ago
Sustained nitric oxide production by engineered E. coli remodels the tumor microenvironment and potentiates immunotherapy
-
Uncategorized5 months agoOptical Pooled CRISPR Screen Reveals Regulators of NF-κB Dynamics in Human Cells
-
Uncategorized4 months ago
Relay’s PI3Kα inhibitor clears efficacy bar in Phase 2 vascular anomalies study
-
STAT News – Biotech6 months agoSTAT+: In private meetings, White House works to win pharma companies’ support for drug pricing bill
-
Nature Biotechnology6 months ago
Mapping cis-regulatory mutations at scale in sorghum enables modulation of gene expression
Scan to Read